After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy — a formulation expressly designed to help users shed pounds — sales of both drugs skyrocketed. Other pharmaceutical giants took notice, and over the past weekend the results of multiple clinical trials from would-be competitors were unveiled at this year’s annual meeting of the… read on > read on >
All Food:
Menopause & Your Diet: Foods to Choose and Avoid
Menopause, a natural stage in a woman’s life, brings a host of changes and challenges. One aspect that is crucial to consider is nutrition. Eating the right foods and avoiding others can help you navigate this change with vitality and optimal health. This article will discuss the key foods to eat and those to avoid… read on > read on >
1.3 Billion People Worldwide Could Have Diabetes by 2050
Diabetes is skyrocketing, with more than 500 million people of all ages living with the disease today and the number of cases worldwide projected to hit 1.3 billion in the next 30 years. “The rapid rate at which diabetes is growing is not only alarming but also challenging for every health system in the world,… read on > read on >
7.5 Million ‘Baby Shark’ Bath Toys Recalled Due to Serious Injuries to Kids
Nearly 8 million Baby Shark and Mini Baby Shark bath toys have been recalled because they can cause serious injuries to children. When using these bath toys, particularly in a bathtub or wading pool, a child can sit, slip or fall onto the shark’s hard plastic top fin, posing risks of impalement, lacerations and puncture… read on > read on >
FDA Approves First Gene Therapy to Treat Duchenne Muscular Dystrophy
The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD). The groundbreaking treatment will not be cheap: Drugmaker Sarepta Therapeutics Inc. said it would charge $3.2 million for the one-time IV treatment, the Associated Press reported. Like most medicines… read on > read on >
First Chicken Meat Grown in Labs Gets U.S. Approval
(HealthDay News) – Americans could soon be eating “lab-grown” chicken at upscale restaurants after the U.S. Department of Agriculture approved products made by two companies on Wednesday. Upside Foods and Good Meat, both based in California, will be the first in the United States to sell meat that’s cultivated in a laboratory rather than from… read on > read on >
Diet Heavy in Omega-3s Might Help Slow ALS
Consuming omega-3 fatty acids like flaxseed oil and walnuts may help slow the decline in physical function related to amyotrophic lateral sclerosis (ALS), new research suggests. ALS (formerly known as Lou Gehrig’s disease) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. People with ALS lose the ability to… read on > read on >
FDA Approves New Drugs to Treat Type 2 Diabetes in Kids
The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provide a new class of medications for pediatric type 2 diabetes. They join… read on > read on >
What Medications Are Used to Treat Alzheimer’s?
While there is no cure for Alzheimer’s, there are medications that can help ease symptoms and slow the progression of this devastating disease. Alzheimer’s disease is the most common type of dementia, affecting over 5.8 million Americans, according to the U.S. Centers for Disease Control and Prevention. Typically affecting older individuals, it begins with mild… read on > read on >
Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
(HealthDay News) – The maker of three popular drugs that treat weight loss and diabetes said Tuesday that it has begun legal proceedings against businesses that are selling compounded versions of its products that are not approved by the U.S. Food and Drug Administration. In a statement, the company said it is telling these med… read on > read on >